Last 25 quarters of trend data · Healthcare · Eye & Dental Care
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -19.57 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 6.20 | 5.18 | 3.16 | 2.58 | 5.16 | 2.26 | 2.73 | 1.76 | 2.42 | 3.93 | 3.89 | 3.39 | 3.36 | 2.05 | 4.28 | 5.62 | 7.16 | 4.07 | 6.22 | 9.24 | 14.18 |
| — | +128.7% | +15.5% | +46.8% | +113.0% | -42.5% | -29.8% | -48.2% | -28.0% | +91.9% | -9.0% | -39.7% | -53.0% | -49.7% | -31.2% | -39.2% | -49.5% | -76.4% | — | — | — | |
| P/B Ratio | 8.22 | 10.50 | 5.59 | 3.77 | 6.58 | 2.80 | 3.06 | 1.59 | 2.11 | 3.34 | 3.27 | 2.39 | 2.10 | 1.29 | 2.95 | 2.89 | 3.68 | 1.76 | 2.24 | 2.59 | 3.59 |
| — | +274.7% | +82.7% | +137.9% | +211.6% | -16.1% | -6.7% | -33.7% | +0.7% | +158.7% | +10.9% | -17.2% | -42.9% | -26.6% | +32.0% | +11.4% | +2.5% | -52.2% | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | 144.42 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 85.9% | 91.4% | 86.2% | 87.3% | 86.4% | 84.8% | 86.2% | 86.8% | 83.9% | 85.8% | 85.5% | 85.2% | 86.6% | 85.6% | 83.8% | 82.2% | 84.3% | 84.1% | 79.6% | 86.8% |
| — | -0.5% | +7.8% | -0.0% | +0.5% | +3.0% | -1.2% | +0.8% | +1.9% | -3.2% | +0.3% | +2.0% | +3.7% | +2.7% | +1.8% | +5.3% | -5.3% | +0.1% | +3.1% | +8.5% | +17.9% | |
| Operating Margin | -48.0% | -24.6% | -16.6% | -63.0% | -18.0% | -39.7% | -59.6% | -79.2% | -62.5% | -55.7% | -59.2% | -76.4% | -59.3% | -67.0% | -64.7% | -93.3% | -83.0% | -117.0% | -132.7% | -149.1% | -100.2% |
| — | +38.1% | +72.1% | +20.4% | +71.2% | +28.7% | -0.7% | -3.6% | -5.6% | +16.9% | +8.5% | +18.1% | +28.6% | +42.7% | +51.2% | +37.4% | +17.2% | -9.2% | -50.2% | -10.5% | -6.8% | |
| Net Margin | -49.7% | -27.3% | -19.0% | -65.9% | -20.4% | -41.0% | -61.0% | -80.8% | -62.1% | -54.9% | -57.7% | -84.4% | -57.0% | -65.1% | -62.9% | -90.7% | -82.3% | -119.0% | -138.4% | -156.3% | -108.5% |
| — | +33.4% | +68.9% | +18.5% | +67.1% | +25.2% | -5.8% | +4.3% | -8.9% | +15.7% | +8.2% | +6.9% | +30.7% | +45.3% | +54.6% | +42.0% | +24.2% | +9.2% | +1.5% | -10.3% | -7.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -50.7% | -13.3% | -8.3% | -22.0% | -6.5% | -12.2% | -16.2% | -17.1% | -13.0% | -11.3% | -11.7% | -14.2% | -8.6% | -9.9% | -10.4% | -11.1% | -10.2% | -12.2% | -11.8% | -10.5% | -6.7% |
| — | -9.7% | +48.5% | -28.5% | +50.0% | -8.1% | -38.3% | -20.9% | -50.2% | -13.7% | -12.0% | -27.3% | +14.8% | +18.7% | +11.6% | -6.3% | -52.3% | +54.3% | — | — | — | |
| ROA | -29.8% | -6.5% | -4.1% | -11.5% | -3.6% | -6.9% | -9.5% | -10.4% | -8.3% | -7.5% | -8.1% | -10.1% | -6.2% | -7.2% | -7.7% | -8.3% | -7.7% | -9.5% | -9.5% | -8.6% | -5.6% |
| — | +5.3% | +56.3% | -11.1% | +56.5% | +9.1% | -17.5% | -2.9% | -32.8% | -4.8% | -4.5% | -21.2% | +19.3% | +24.5% | +19.1% | +3.5% | -38.3% | +4.5% | +69.4% | +53.0% | +55.4% | |
| ROIC | -274.4% | -31.7% | -22.6% | -79.4% | -21.7% | -54.7% | -95.1% | -123.4% | -93.2% | -55.8% | -53.6% | -64.1% | -48.0% | -59.8% | -75.1% | -109.9% | -146.1% | -244.3% | -253.5% | -252.2% | -154.6% |
| — | +41.9% | +76.2% | +35.6% | +76.7% | +2.1% | -77.5% | -92.3% | -94.2% | +6.6% | +28.7% | +41.6% | +67.2% | +75.5% | +70.4% | +56.4% | +5.5% | -100.9% | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.64 | 0.86 | 0.79 | 0.77 | 0.64 | 0.63 | 0.58 | 0.52 | 0.46 | 0.37 | 0.34 | 0.32 | 0.29 | 0.27 | 0.26 | 0.24 | 0.22 | 0.20 | 0.18 | 0.16 | 0.15 |
| — | +35.4% | +36.9% | +48.6% | +38.3% | +70.3% | +68.2% | +62.6% | +56.5% | +36.2% | +34.9% | +34.5% | +34.8% | +37.4% | +42.9% | +47.4% | +48.3% | +43.0% | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 10.22 | 5.04 | 4.95 | 5.86 | 10.22 | 9.60 | 10.01 | 10.47 | 9.04 | 10.18 | 11.01 | 13.01 | 13.29 | 12.11 | 12.97 | 12.79 | 11.77 | 12.79 | 16.73 | 21.28 | 20.52 |
| — | -47.5% | -50.5% | -44.0% | +13.1% | -5.7% | -9.1% | -19.5% | -32.0% | -15.9% | -15.1% | +1.7% | +13.0% | -5.3% | -22.5% | -39.9% | -42.6% | -54.2% | +325.8% | +243.8% | +170.5% | |
| Quick Ratio | 9.52 | 4.72 | 4.67 | 5.48 | 9.52 | 8.93 | 9.49 | 9.99 | 8.63 | 9.74 | 10.50 | 12.42 | 12.65 | 11.47 | 12.41 | 12.32 | 11.43 | 12.47 | 16.38 | 20.94 | 20.26 |
| — | -47.2% | -50.8% | -45.2% | +10.3% | -8.3% | -9.7% | -19.6% | -31.8% | -15.1% | -15.4% | +0.8% | +10.7% | -8.1% | -24.2% | -41.2% | -43.6% | -54.8% | +340.9% | +253.9% | +177.3% | |
| Interest Coverage | -6.47 | -4.18 | -3.60 | -9.23 | -2.22 | -5.32 | -8.27 | -10.17 | -9.17 | -8.47 | -9.75 | -12.50 | -6.91 | -8.05 | -9.93 | -12.36 | -12.82 | -18.64 | -21.38 | -21.23 | -13.69 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 25 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SGHT stock.
Sight Sciences, Inc.'s current P/E is -19.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Sight Sciences, Inc.'s current operating margin is -48.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sight Sciences, Inc.'s business trajectory between earnings reports.